ApoE-Dependent Modulation of HDL and Atherosclerosis by G2A in LDL Receptor–Deficient Mice Independent of Bone Marrow–Derived Cells
Open Access
- 1 April 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 29 (4), 539-547
- https://doi.org/10.1161/ATVBAHA.108.179937
Abstract
Objective— Deletion of the lysophospholipid-sensitive receptor, G2A, in low-density lipoprotein receptor knockout (LDLR −/− ) mice elevates plasma high-density lipoprotein (HDL) cholesterol and suppresses atherosclerosis. However, chemotactic action of G2A in monocytes/macrophages, in addition to its modulatory effect on HDL, may contribute to the proatherogenic action of G2A. Methods and Results— We determined that deletion of G2A in LDLR −/− mice increases the ApoA1, ApoE, and cholesterol content of plasma HDL fractions. Hepatocytes were shown to express G2A and hepatocytes from G2A-deficient LDLR −/− mice secreted more ApoA1 and ApoE in HDL fractions compared to their G2A-sufficient counterparts. The atheroprotective and HDL modulatory effects of G2A deficiency were dependent on the presence of ApoE, as deletion of G2A in ApoE −/− and ApoE −/− LDLR −/− mice failed to raise HDL and did not suppress atherosclerosis. G2A deficiency in bone marrow–derived cells of LDLR −/− mice had no effect on atherosclerosis or HDL, whereas G2A deficiency in resident tissues was sufficient to raise HDL and suppress atherosclerosis. Conclusion— These data demonstrate that the chemotactic function of G2A in bone marrow–derived monocytes does not modulate atherosclerosis in LDLR −/− mice and suggest an ApoE-dependent function for G2A in the control of hepatic HDL metabolism that might contribute to its proatherogenic action.Keywords
This publication has 27 references indexed in Scilit:
- Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wallJournal of Lipid Research, 2009
- G2A as a receptor for oxidized free fatty acidsProstaglandins & Other Lipid Mediators, 2009
- Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors*Journal of Lipid Research, 2008
- The Interplay between Size, Morphology, Stability, and Functionality of High-Density Lipoprotein SubclassesBiochemistry, 2008
- Migration to Apoptotic “Find-me” Signals Is Mediated via the Phagocyte Receptor G2AJournal of Biological Chemistry, 2008
- Absence of the G Protein–Coupled Receptor G2A in Mice Promotes Monocyte/Endothelial Interactions in AortaCirculation Research, 2007
- Loss of the Lysophosphatidylcholine Effector, G2A, Ameliorates Aortic Atherosclerosis in Low-Density Lipoprotein Receptor Knockout MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Loss of G2A promotes macrophage accumulation in atherosclerotic lesions of low density lipoprotein receptor-deficient miceJournal of Lipid Research, 2005
- Cell-derived Apolipoprotein E (ApoE) Particles Inhibit Vascular Cell Adhesion Molecule-1 (VCAM-1) Expression in Human Endothelial CellsPublished by Elsevier BV ,2001
- Influence of macrophage-derived apoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apoprotein E-deficient miceBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1997